PT Jayamas Medica Industri Tbk (ISX:OMED) Beneish M-Score: -2.08 (As of Jun. 27, 2026)


ISX:OMED PT Jayamas Medica Industri Tbk ISX:OMED
91 GF Score
Price Rp206.00
GF Value Rp236.50
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Jayamas Medica Industri Tbk Beneish M-Score?

PT Jayamas Medica Industri Tbk ISX:OMED -5.50% 91 Beneish M-Score is -2.08 as of Jun. 27, 2026. GuruFocus rates ISX:OMED with a GF Score™ of 91/100 and a GF Value™ of Rp236.50 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 766 Medical Devices & Instruments companies, PT Jayamas Medica Industri Tbk ranks worse than 78.46% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.08 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Jayamas Medica Industri Tbk's Beneish M-Score or its related term are showing as below:

ISX:OMED' s Beneish M-Score Range Over the Past 10 Years
Min: -2.68   Med: -2.14   Max: -1.79
Current: -2.08

During the past 7 years, the highest Beneish M-Score of PT Jayamas Medica Industri Tbk was -1.79. The lowest was -2.68. And the median was -2.14.


PT Jayamas Medica Industri Tbk Beneish M-Score Historical Data

* Premium members only.

The historical data trend for PT Jayamas Medica Industri Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Jayamas Medica Industri Tbk Beneish M-Score Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -1.96 -2.37 -2.20

PT Jayamas Medica Industri Tbk Quarterly Data
Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -1.79 -1.93 -2.20 -2.08

ISX:OMED vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Jayamas Medica Industri Tbk Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Jayamas Medica Industri Tbk's Beneish M-Score falls into.


ISX:OMED
91GF Score
PT Jayamas Medica Industri Tbk ISX:OMED
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Jayamas Medica Industri Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Jayamas Medica Industri Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9545+0.528 * 0.9452+0.404 * 1.7373+0.892 * 1.161+0.115 * 1.0699
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0718+4.679 * 0.017362-0.327 * 1.1318
=-2.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was Rp303,490 Mil.
Revenue was 572248.286 + 593922.691 + 544048.076 + 489530.669 = Rp2,199,750 Mil.
Gross Profit was 205929.494 + 219209.568 + 185517.096 + 165872.195 = Rp776,528 Mil.
Total Current Assets was Rp2,497,787 Mil.
Total Assets was Rp3,321,884 Mil.
Property, Plant and Equipment(Net PPE) was Rp527,992 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp22,715 Mil.
Selling, General, & Admin. Expense(SGA) was Rp151,678 Mil.
Total Current Liabilities was Rp225,426 Mil.
Long-Term Debt & Capital Lease Obligation was Rp217,526 Mil.
Net Income was 98369.588 + 112740.269 + 100477.171 + 80967.619 = Rp392,555 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was 43273.284 + 155745.942 + 74599.091 + 61262.603 = Rp334,881 Mil.
Total Receivables was Rp273,865 Mil.
Revenue was 436315.465 + 521327.012 + 484846.968 + 452259.622 = Rp1,894,749 Mil.
Gross Profit was 146896.784 + 177025.845 + 154948.834 + 153345.703 = Rp632,217 Mil.
Total Current Assets was Rp2,321,624 Mil.
Total Assets was Rp2,936,534 Mil.
Property, Plant and Equipment(Net PPE) was Rp464,239 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp21,433 Mil.
Selling, General, & Admin. Expense(SGA) was Rp121,898 Mil.
Total Current Liabilities was Rp328,655 Mil.
Long-Term Debt & Capital Lease Obligation was Rp17,323 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(303489.804 / 2199749.722) / (273865.113 / 1894749.067)
=0.137966 / 0.144539
=0.9545

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(632217.166 / 1894749.067) / (776528.353 / 2199749.722)
=0.333668 / 0.353008
=0.9452

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2497787.467 + 527991.539) / 3321884.497) / (1 - (2321623.85 + 464239.081) / 2936534.223)
=0.089138 / 0.051309
=1.7373

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2199749.722 / 1894749.067
=1.161

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(21433.019 / (21433.019 + 464239.081)) / (22715.346 / (22715.346 + 527991.539))
=0.044131 / 0.041248
=1.0699

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(151678.191 / 2199749.722) / (121898.208 / 1894749.067)
=0.068952 / 0.064335
=1.0718

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((217526.055 + 225425.533) / 3321884.497) / ((17323.464 + 328655.267) / 2936534.223)
=0.133343 / 0.117819
=1.1318

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(392554.647 - 0 - 334880.92) / 3321884.497
=0.017362

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Jayamas Medica Industri Tbk has a M-score of -2.08 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.08 mean?
PT Jayamas Medica Industri Tbk (ISX:OMED) has a Beneish M-Score of -2.08 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Jayamas Medica Industri Tbk and its competitors. According to the industry distribution chart, PT Jayamas Medica Industri Tbk ranks #601 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 78.5%.
Is PT Jayamas Medica Industri Tbk's Beneish M-Score too high?
PT Jayamas Medica Industri Tbk's current Beneish M-Score is -2.08. Based on the distribution chart, PT Jayamas Medica Industri Tbk ranks #601 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Jayamas Medica Industri Tbk ranks #601 out of 766 companies for Beneish M-Score. This places PT Jayamas Medica Industri Tbk in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Jayamas Medica Industri Tbk and its competitors. PT Jayamas Medica Industri Tbk's current Beneish M-Score is -2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp236.50, compared to a current price of Rp206.00 — trading 12.9% below its estimated fair value. The current Beneish M-Score is -2.08. PT Jayamas Medica Industri Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current Beneish M-Score is -2.08 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?

Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued. The current stock price of Rp206.00 is trading 12.9% below its estimated GF Value™ of Rp236.50. GuruFocus considers PT Jayamas Medica Industri Tbk to be Modestly Undervalued.

Key valuation signals for ISX:OMED:

  • Beneish M-Score: -2.08
  • GF Value™: Rp236.50 vs. price of Rp206.00 (12.9% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Jayamas Medica Industri Tbk Business Description

Address Sebelah Selatan Jalan By Pass RT 05 / RW 01, Sidomojo Village, Krian District, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
91GF Score

Get the complete analysis for ISX:OMED

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp206.00
Price
Rp236.50
GF Value